The impact of pathogen reduction on ABO isoagglutinin titers in apheresis platelets

Background: Platelet transfusions are a cornerstone of modern medical care, used across various clinical contexts. Ensuring the compatibility of blood products, especially regarding ABO isoagglutinins, is critical to minimize adverse reactions. Pathogen reduction technologies have been widely adopte...

Full description

Bibliographic Details

Published in:	Hematology, Transfusion and Cell Therapy
Main Authors:	Mikayel Yeghiazaryan, Yembur Ahmad, Jessie Singer, Vaanush Nazaryan, Craig Fletcher, Yamac Akgun
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Subjects:	Pathogen reduction Apheresis platelets Isoagglutinin titers Solid phase
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137925001087